[144] Verisk Analytics, Inc. SEC Filing

Rhea-AI Filing Summary

Verisk Analytics, Inc. (VRSK) Form 144 discloses a proposed sale of 300 shares of common stock through Merrill Lynch with an aggregate market value of $76,416, scheduled approximately for 09/16/2025 on NASDAQ. The shares were acquired on 10/01/2023 upon vesting of a restricted stock unit award granted under the issuers equity compensation plan. The filer previously sold three blocks of 300 shares each on 06/17/2025, 07/15/2025, and 08/15/2025 realizing gross proceeds of $92,670, $91,164, and $80,400, respectively. The Form 144 includes the required attestation about material nonpublic information; no additional terms, plan adoption date, or signature date are provided in the text.

Positive

• Disclosure complies with Rule 144 by identifying broker, share count, acquisition method, and recent sales
• Securities originated from issuer equity compensation (vesting of restricted stock units), clarifying the acquisition source

Negative

• Recent sales show multiple disposals of 300-share blocks over the past three months, which may be of interest to investors
• Provided text lacks explicit signature or notice date, which is present on completed filings but is not included in the supplied content

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for an equity-compensation-originated sale; prior small blocks were sold in recent months.

The filing reports a small proposed sale of 300 shares derived from vesting of restricted stock units and executed via a broker on NASDAQ. The sale size is negligible relative to the reported shares outstanding of 139,714,971, indicating limited direct impact on market supply. Recent past sales of three 300-share blocks are disclosed with exact gross proceeds, showing the holder has been selling modest, periodic blocks. This is a standard disclosure under Rule 144 documenting an intended sale and the acquisition source.

Compliance/Risk Analyst

TL;DR: Filing satisfies Rule 144 disclosure requirements; contains the attestation but lacks signature/notice dates in provided text.

The Form 144 includes the necessary details about the broker, number of shares, acquisition method (vesting of RSUs), and recent sales, which supports compliance with resale reporting obligations. The document also contains the attestation regarding material nonpublic information. The filing, as provided, does not show a signature date or explicit date of notice adoption, which are typically present on submitted forms; that absence is notable in the supplied content but not necessarily indicative of noncompliance without the complete filing form.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty St Floor 37 New York NY 10281	300	76416.00	139714971	09/16/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/01/2023	Vesting of restricted stock unit award	Verisk Analytics, Inc.			300	10/01/2023	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Elizabeth Mann 545 WASHINGTON BOULEVARD JERSEY CITY NJ 07310-1686	Common Stock	08/15/2025	300	80400.00
Elizabeth Mann 545 WASHINGTON BOULEVARD JERSEY CITY NJ 07310-1686	Common Stock	07/15/2025	300	91164.00
Elizabeth Mann 545 WASHINGTON BOULEVARD JERSEY CITY NJ 07310-1686	Common Stock	06/17/2025	300	92670.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for VRSK disclose about the proposed sale?

The filing discloses a proposed sale of 300 shares via Merrill Lynch with aggregate market value $76,416, approx. sale date 09/16/2025 on NASDAQ.

How were the 300 shares acquired according to the filing?

The shares were acquired on 10/01/2023 upon vesting of a restricted stock unit award granted under Verisk Analytics equity compensation plan.

Has the filer sold other Verisk (VRSK) shares recently?

Yes. The filer sold 300 shares on 06/17/2025 (gross proceeds $92,670), 07/15/2025 ($91,164), and 08/15/2025 ($80,400).

How large is the proposed sale relative to shares outstanding?

The proposed 300-share sale is small relative to the reported 139,714,971 shares outstanding, per the filing.

Does the filing state whether the filer knows material nonpublic information?

The Form 144 includes the required attestation that the person signing represents they do not know any material adverse information that is not publicly disclosed.